Antimony-containing Substances Group

These substances were identified for action under the Chemicals Management Plan (CMP). 

Summary of publications

Substance group CAS RN Common name DSL name Draft screening assessment Proposed conclusion on section 64 criteria Follow-up activities
Antimony-containing Substance Group 1314-60-9 Antimony pentoxide Antimony oxide (Sb2O5) HTML Does not meet None planned at this time
1327-33-9a Antimony oxide Antimony oxide
1345-04-6 Antimony sulfide Antimony sulfide (Sb2S3)
10025-91-9 Antimony trichloride Stibine, trichloro-
15432-85-6 Sodium antimonate Antimonate (SbO31-), sodium
15874-48-3 NA Phosphorodithioic acid, O,O-dipropyl ester, antimony(3+) salt
15890-25-2 Antimony diamyldithiocarbamate Antimony, tris(dipentylcarbamodithioato-S,S’)-, (OC-6-11)-
15991-76-1 NA Antimony, tris[bis(2-ethylhexyl)carbamodithioato-S,S’]-, (OC-6-11)-
28300-74-5 Antimony potassium tartrate (APT) Antimonate(2-), bis[µ-[2,3-di(hydroxy-κO)butanedioato(4-)-κO1:κO4]]di-, dipotassium, trihydrate, stereoisomer
29638-69-5 Potassium antimonate Antimonate (Sb2O74-), tetrapotassium
33908-66-6 Sodium hexahydroxoantimonate Antimonate (Sb(OH)61-), sodium, (OC-6-11)-

Timelines

Date Activity
September 2019 Anticipated publication of the final screening assessment.
September 15, 2018 Publication and start of 60-day public comment period on the draft screening assessment.  The related notice was published in the Canada Gazette, Part I: Vol. 152, No. 37.
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: